Labshake search
Citations for R&D Systems :
1301 - 1350 of 3688 citations for En 1948 4 Marker Pcb Extraction Spike 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2019Quote: ... and IL-6 (100 pg/ml; R&D Systems).
-
bioRxiv - Immunology 2022Quote: ... anti-TLR2 mAb (100 μg/ml, R&D system), or a mixture of anti-CLEC5A mAb and anti-TLR2 mAb for 30 min at room temperature before incubation with SARS-CoV-2 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and IL-2 (100 U/ml; R&D Systems) at 37°C and 5% CO2 ...
-
bioRxiv - Cell Biology 2024Quote: ... and 100 µg/mL streptomycin (R&D Systems, B21210) at 37°C ...
-
bioRxiv - Immunology 2020Quote: ... were seeded at a concentration of 1 × l06 cells/ml in RPMI 1640 medium supplemented with 20 ng/ml GM-CSF (415-ML-050, R&D Systems, USA). After 7 d of culture ...
-
bioRxiv - Immunology 2020Quote: ... and 1 μg/ml CD40-ligand-HA with 5 ng/ml anti-HA antibodies (R&D Systems, Minneapolis, USA), and separately in combination with IL-4 and IL-21 (100 IU each) ...
-
bioRxiv - Biophysics 2022Quote: ... The medium was supplemented with 10 ng/ml recombinant mouse IL-2 (rmIL-2) (402-ML, R&D systems) for long-term culture of mouse ILC2s.
-
bioRxiv - Bioengineering 2023Quote: ... Plates were incubated with PBSTBA diluted 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) for 2 h at RT ...
-
bioRxiv - Immunology 2023Quote: ... 2.5% HEPES and stimulated with 50ng/ml IL-4 (R&D Systems Cat: 404-ML) for 15 minutes at 37°C ...
-
bioRxiv - Immunology 2023Quote: ... and 25ng/ml recombinant mouse IL-4 (clone 404-ML-025/CF; R&D System) in final volume of 200 μl of RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Immunology 2021Quote: ... 4 μg/mL of each Siglec-Fc (R&D Systems) was pre-complexed with either 8 μg/mL AffiniPure Donkey anti-human IgG Alexa Fluor 647 (Jackson ImmunoResearch ...
-
bioRxiv - Immunology 2020Quote: ... Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems; R15-100). R15-100 was added every 2 to 3 days thereafter ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 5 ng mL-1 of IL-7 and IL-15 (R&D Systems). Regulatory T cells were activated at 1 x 106 cells mL-1 for 2 days in complete XVivo15 supplemented with magnetic Treg Xpander CTS Dynabeads (ThermoFisher ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 30 ng/ml Activin A (R&D systems cat. no. 338-AC-050). After 24 hours ...
-
bioRxiv - Developmental Biology 2021Quote: ... 21985-023)] with freshly added 50 ng/ml Bmp4 (R&D Systems, cat. 314-BP-010), 50 ng/ml Bmp8a (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... and 20 ng/ml basic fibroblast growth factor (bFGF, # 233-FB; R&D Systems) until day 24 ...
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Microbiology 2019Quote: ... 20 ng/ml epidermal growth factor (catalog number 236-EG-01M; R&D Systems), GlutaMAX (catalog number 35050061 ...
-
bioRxiv - Microbiology 2019Quote: ... 20 ng/ml fibroblast growth factor (catalog number 4114-TC-01M; R&D Systems), 20 ng/ml epidermal growth factor (catalog number 236-EG-01M ...
-
bioRxiv - Developmental Biology 2021Quote: ... 0.1% β-ME and 30 ng/ml of Activin A (R&D Systems, USA).
-
bioRxiv - Bioengineering 2020Quote: ... and 2.5 ng mL−1 recombinant mouse FGF2 (R&D Systems # 3139-FB-025). In some experiments ...
-
bioRxiv - Cell Biology 2021Quote: ... 0.1% 2-Mercaptoethanol and 10 ng/mL basic FGF (R&D Systems, 233-FB). For MyoD+F/R/C condition ...
-
bioRxiv - Neuroscience 2021Quote: ... 0.1 ng/ml rat glial cell line-derived neurotrophic factor (GDNF; R&D systems), 1 ng/ml human brain-derived neurotrophic factor (BDNF ...
-
bioRxiv - Pathology 2021Quote: ... 1% antibiotics and 10 ng/ml basic fibroblast growth factor (bFGF) (R&D Systems). Human MPCs were trypsinized and incubated 30 min with biotinylated anti-human PDGFRα (R&D system ...
-
bioRxiv - Cell Biology 2020Quote: ... 40 ng/ml basic fibroblast growth factor (bfgf, R&D Systems, 233-FB/CF), 1X non-essential amino acids ...
-
bioRxiv - Cell Biology 2022Quote: ... together with human vascular endothelial growth factor (hVEGF, 5 ng/ml; R&D Systems). Cardiac specification was induced by exposure of cells to StemPro-34 SF medium (Gibco ...
-
bioRxiv - Biophysics 2022Quote: ... 0.4 mM proline and 10 ng/ml TGF-β3 (R&D Systems, Minneapolis, MN). Differentiation was carried out for 3 weeks ...
-
bioRxiv - Immunology 2022Quote: ... Pathogenic Th17 cells were differentiated with IL-1β (20 ng/mL, R&D Systems), IL-6 (25ng/mL ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... and the WNT signalling pathway inhibitor IWR1-endo (1 ng/ml, R&D Systems), which was refreshed after 48 h ...
-
bioRxiv - Molecular Biology 2021Quote: ... basic fibroblast growth factor (bFGF, 20 ng/mL, Cat. #4114-TC; R&D Systems), and gentamicin sulfate (50 μg/mL).
-
bioRxiv - Physiology 2019Quote: ... and incubated with 50 ng/ml biotinylated mouse VEGF-A (R&D Systems, USA) for 30 min at 37°C ...
-
bioRxiv - Cancer Biology 2020Quote: ... cells were either treated with 10 ng/ml IL4 (R&D Systems, Abingdon, UK) or left untreated and incubated for 24 hours at 37°C/5%CO2 ...
-
bioRxiv - Immunology 2019Quote: ... MN) in combination with hrIFNβ at 2 ng/ml (R&D Systems, Minneapolis, MN) or when indicated hrISG15 at 0.115 μg/ml (Biotechne ...
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Cell Biology 2020Quote: ... and were treated with 10 ng/mL TGF-β1 (R&D systems, 240-B) or IMRC conditioned medium where specified ...
-
bioRxiv - Biochemistry 2021Quote: ... Treatments with human recombinant 10 ng/ml TGF-β1 (R&D Systems, Minneapolis, MN) were performed after serum-free starvation for 12 hours (h).
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml transforming growth factor beta one (TGFβ1, recombinant human, R&D systems) 25 μg/mL l-ascorbic acid 2-phosphate (Sigma Aldrich) ...
-
bioRxiv - Biochemistry 2021Quote: ... and 30 ng/ml macrophage colony-stimulating factor (M-CSF; R&D Systems, USA) at 37°C and 5% CO2 for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... 1% (v/v) B27 and 50 ng/ml EGF (R&D System, 236-EG). Cells were then dissociated using TrypLE™ Express (Life Technology ...
-
Immunoresolvents Support Skeletal Myofiber Regeneration via Actions on Myeloid and Muscle Stem CellsbioRxiv - Immunology 2020Quote: ... and human recombinant GM-CSF (20 ng/mL) (R&D Systems, 215-GM-010). Cells then were washed with PBS to remove non-adherent cells and detached by incubation in TrypLE Select at 37°C followed by gentle cell scraping ...
-
bioRxiv - Immunology 2021Quote: ... tumor necrosis factor (TNF)-α (25 ng/mL; R&D Systems Cat# 210-TA), and polyinosinic:polycytidylic acid (20 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... in the presence of 50 ng/mL M-CSF (216-MC; R&D Systems) and 50 ng/mL GM-CSF (215-GM ...
-
bioRxiv - Immunology 2020Quote: ... Fibroblasts were stimulated with 10 ng/mL TNF-α (210-TA; R&D Systems) and 10 ng/mL IFN-γ (285-IF ...
-
bioRxiv - Immunology 2020Quote: ... R&D systems)26 or alternative activated (regulatory) M2 macrophages (40 ng/mL IL4;R&D systems)26 ...
-
bioRxiv - Immunology 2022Quote: ... and 25 ng/mL human recombinant M-CSF (#216-MC, R&D Systems Inc). Cells were differentiated for 7-10 days prior to treatment as has previously been shown to yield mature macrophages (44) ...
-
bioRxiv - Cancer Biology 2022Quote: ... cells were stimulated with 50 ng/ml recombinant human BMP-9 (R&D Systems) and 150 ng/ml recombinant human VEGF (PeproTech ...
-
bioRxiv - Biophysics 2022Quote: ... 0.004% (40 ng/mL) basic fibroblast growth factor (R&D Systems, 233-FB/CF), 1× non-essential amino acids ...
-
bioRxiv - Molecular Biology 2022Quote: ... the transfected cells were treated with 5 ng/ml TGF-β1 (R&D Systems) for 24 hours ...